Surge in Infant Bleeding Cases Tied to Declining Vitamin K Shot Acceptance
Recent studies have unveiled a concerning trend in infant health, linking a significant rise in vitamin K shot refusals among newborns to an alarming increase in cases of vitamin K deficiency bleeding (VKDB). Analysis of data from millions of infants in the United States indicates that the rate of refusal for this essential nutrient injection has more than doubled from 3.1% in 2017 to 6.8% in 2025. This decline in vitamin K administration correlates with a nearly fourfold increase in VKDB cases, which can lead to severe health complications, including brain hemorrhages.
Published on November 5 in reputable medical journals, the findings reveal that the risk of bleeding is 47% higher for infants who do not receive the vitamin K shot. These infants also face more than double the risk of experiencing intracranial bleeding, a potentially life-threatening condition. The vitamin K shot has been shown to reduce the likelihood of late-onset VKDB by approximately 98%.
Vitamin K is crucial for blood clotting, and newborns naturally have low levels of this vitamin. Without the preventive injection, they are susceptible to VKDB, which can cause sudden bleeding in various organs, including the brain and gastrointestinal tract. Late-onset VKDB can develop up to six months after birth, often without warning signs, making the shot an essential preventive measure.
The Centers for Disease Control and Prevention (CDC) and the American Academy of Pediatrics (AAP) strongly advocate for the administration of vitamin K shots to all newborns, ideally within the first six hours of life. Despite this, experts attribute the rising refusal rates to a combination of vaccine hesitancy, misinformation circulating on social media, and conflicting messaging from health authorities.
Dr. Graham Tse, a pediatrician and chief medical officer at MemorialCare, emphasizes that the decision to administer the vitamin K shot is complex and influenced by various factors, including public confusion stemming from mixed health recommendations. Some parents mistakenly equate the vitamin K shot with vaccinations, overlooking its critical role in preventing serious bleeding.
Recent data from Truveta indicates that the trend of declining vitamin K shot acceptance is ongoing, with refusals rising by 57% from January to June 2026. This growing distrust in the medical community has led some parents to decline routine newborn care, including this crucial injection.
Dr. Tse warns that refusing the vitamin K shot puts infants at significant risk for VKDB, which can manifest as minor symptoms like skin bruising or escalate to severe internal bleeding. He urges parents to understand that the vitamin K shot is not a vaccine but a necessary nutrient injection that has been proven safe and effective in preventing life-threatening complications associated with vitamin K deficiency.
As public health officials continue to combat misinformation and clarify the importance of the vitamin K shot, parents are encouraged to stay informed and prioritize their newborns’ health by ensuring they receive this vital preventive treatment at birth.
